HOME ·

06855.HK

ASCENTAGE (06855.HK): Interim Revenue Up 29.3% to RMB 302.2 Million, Net Loss Widens to RMB 817.0 Million
Tags：
NewTimeSpaceASCENTAGE06855.HK
2026-09-17
ASCENTAGE(06855.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 816.69 million, loss widened by 38.24% YoY
Tags：
ASCENTAGE06855.HKLoss widens
2026-08-20
Ascentage Pharma (06855.HK): Appoints Dr. Faïçal Miyara as CBO and Jim Ziegler as CCO to Strengthen Global Commercialization
Tags：
ASCENTAGE06855.HK
2026-08-03